Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 9:17 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1129–1152 of 1,600 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Skin Patch Clear all

Conditions: Needle Phobia
Interventions: Lidocaine patch 4%, Placebo Patch, 1% Lidocaine Skin Wheal; Drug · Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Hypoactive Sexual Desire Disorder (HSDD)
Interventions: Testosterone Transdermal System, Placebo patch; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 40 Years to 70 Years · Female only
Enrollment: 549 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2003
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Tobacco Dependence
Interventions: nicotine patch, nicotine lozenge, bupropion, patch + lozenge, bupropion + lozenge; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 1,346 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Nicotine Dependence
Interventions: varenicline, transdermal nicotine patch; Drug · Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Smoking, Cardiovascular Disease Risk
Interventions: Resistance Training (RT), Nicotine Replacement Therapy (NRT); Other · Biological
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 35 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Post-operative Nausea, Post-operative Vomiting, Nausea Persistent
Interventions: Antiemetic anesthesia protocol; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 15 Years and older
Enrollment: 233 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Amblyopia
Interventions: patching, binocular games; Other
Lead sponsor: Retina Foundation of the Southwest; Other
Eligibility: 4 Years to 14 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: WearME-Pro Patch System, FDA-cleared handheld spirometer (reference comparator), Cardea SOLO ECG patch (optional subset; exploratory HR reference); Device
Lead sponsor: LASARRUS Clinic and Research Center; Industry
Eligibility: 21 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: Baltimore, Maryland • Salisbury, Maryland

Conditions: Hematologic Malignancy
Interventions: TempTraq, VitalTraq; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Patients With Symptoms of Cardiac Arrhythmia at Risk for Atrial Fibrillation
Interventions: Not listed
Lead sponsor: Scripps Translational Science Institute; Other
Eligibility: 18 Years and older
Enrollment: 928 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Cigarette Smoking
Interventions: Nicotine Patch, SPECTRUM Nicotine Research Cigarettes (0.07 mg), MCE-; Drug · Behavioral
Lead sponsor: Francis McClernon, Ph.D.; Other
Eligibility: 18 Years to 65 Years
Enrollment: 87 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Headache
Interventions: Sphenopalatine ganglion Block, Epidural blood patch; Drug · Procedure
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Chronic Pain, Osteoarthritis of the Knee
Interventions: Buprenorphine, Placebo; Drug
Lead sponsor: Purdue Pharma LP; Industry
Eligibility: 40 Years and older
Enrollment: 567 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 87
States / cities: Mobile, Alabama • Chandler, Arizona • Phoenix, Arizona + 73 more

Conditions: Migraine Disorders
Interventions: Sumatriptan succinate, NP101 Study Patch; Drug
Lead sponsor: NuPathe Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Hallandale, Florida

Conditions: Rotator Cuff Tear
Interventions: Rotator Cuff Repair with Allograft Patch, Rotator Cuff Repair with No Augmentation; Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Erythema, Sensitisation
Interventions: CB-0002B; Other
Lead sponsor: CAGE Bio Inc.; Industry
Eligibility: 21 Years to 67 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: New City, New York

Conditions: Healthy
Interventions: transdermal nicotine patch (7mg); Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 45 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Osteoarthritis of the Knee
Interventions: ketoprofen Patch, Placebo Patch; Drug · Other
Lead sponsor: Hisamitsu Pharmaceutical Co., Inc.; Industry
Eligibility: 45 Years and older
Enrollment: 380 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 36
States / cities: Birmingham, Alabama • Chandler, Arizona • Peoria, Arizona + 31 more

Conditions: Smoking, Tobacco Use Cessation
Interventions: MBAT Group Therapy, Nicotine, Group Therapy, Individual Therapy; Behavioral · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 650 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Contact Dermatitis, Allergy; Dermatitis, Dermatitis
Interventions: Sensitivity Patch Testing; Diagnostic Test
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 90 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Actinic Keratoses
Interventions: MAL 16.8% cream, MAL Vehicle Cream; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years and older
Enrollment: 557 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 59
States / cities: Tucson, Arizona • Fort Smith, Arkansas • Encinitas, California + 52 more

Conditions: Orthostatic Intolerance
Interventions: Ganirelix acetate, 17β-Oestradiol, Progesterone; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 34 Years · Female only
Enrollment: 109 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Smoking, Alcoholism
Interventions: Cognitive Behavior Therapy for alcohol and smoking cessation, Nicoderm CQ nicotine patch, Placebo gum, Nicotine gum - Nicorette®; Behavioral · Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Newington, Connecticut

Conditions: Mild Cognitive Impairment
Interventions: Nicotine Transdermal Patch, Placebo Patch; Drug
Lead sponsor: University of Southern California; Other
Eligibility: 55 Years to 90 Years
Enrollment: 348 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 36
States / cities: Scottsdale, Arizona • North Little Rock, Arkansas • Downey, California + 31 more

Search by objective public record fields.

Lidocaine Patch for Epidural Placement Pain in Laboring Women

Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

Smoking Cessation Intervention: Effectiveness in Primary Care

Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity

Effect of Resistance Training on Tobacco-Related Cardiovascular Disease Risk

Study of Anesthesia Techniques to Reduce Nausea and Vomiting After Jaw Corrective Surgery

Binocular iPad Sub-Study

WearME-Pro Phase II: Remote Use Usability and Longitudinal Validation Study (Patch Form Factor).

VitalTraq for the Detection of CRS

THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring

Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue)

Treatment of Post-dural Puncture Headache in Postpartum Patients: Sphenopalatine Ganglion Block to Epidural Blood Patch.

Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee

Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period

Decellularized Human Placental Extracellular Matrix Tissue for Rotator Cuff Repair Augmentation

50 Human Subject Repeat Insult Patch Test

Nicotine Patch, Blood Flow and Oxidative Stress Study

HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain

Group Therapy for Nicotine Dependence: Mindfulness and Smoking

Study on Hypoallergenic Hair Dye

Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face

Sex Hormones and Orthostatic Tolerance

Combination Nicotine Replacement for Alcoholic Smokers

Memory Improvement Through Nicotine Dosing (MIND) Study